ONCO.CNCNQHealthcare · Biotechnology

Onco-Innovations Ltd.

$1.15+12.75%(+$0.13)

TickerSpark Score

35/100

Weak

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ONCO.CN research report →

52-Week Range28% of range

Low $0.50

Current $1.15

High $2.80

Companyoncoinnovations.com

Onco-Innovations Ltd. is a Canadian biotech company, which engages in cancer research and treatment, specializing in oncology. Its product includes the ONC010 for cancer treatments.

CEO: Thomas O'Shaughnessy
IPO: 2024
Employees: 1
HQ: Calgary, AB, CA

Price Chart

-22.15% · this period

Valuation

Market Cap: $49.88M
P/E: -105.18
P/S: 0.00
P/B: 121.93
EV/EBITDA: -185.91
Div Yield: 0.00%

Profitability

Gross Margin: 0.00%
Op Margin: 0.00%
Net Margin: 0.00%
ROE: -220.58%
ROIC: 0.00%

Growth & Income

Revenue: $0 · 0.00%
Net Income: $-420,654 · -179666.67%
EPS: $-0.01 · -180764.53%
Op Income: $0
FCF YoY: -2603.43%

Performance & Tape

52W High: $2.80
52W Low: $0.50
50D MA: $2.04
200D MA: $1.61
Beta: 8.62
Avg Volume: 422.22K

Get TickerSpark's AI analysis on ONCO.CN

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime